Notice NOT-DK-20-029 from the NIH Guide for Grants and Contracts

Notice NOT-DK-20-030 from the NIH Guide for Grants and Contracts

Notice NOT-TW-20-006 from the NIH Guide for Grants and Contracts

Notice NOT-TW-20-005 from the NIH Guide for Grants and Contracts

Notice NOT-DE-20-025 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-20-151 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required

Funding Opportunity PA-20-149 from the NIH Guide for Grants and Contracts. The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Notice NOT-DA-20-057 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-012 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-013 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-010 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-011 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-030 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-067 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-20-206 from the NIH Guide for Grants and Contracts. The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Notice NOT-DA-20-041 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-017 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-052 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-20-030 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-18-032. The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to Program Directors (PDs) /Principal Investigators (PIs) whose records of research achievement demonstrate their ability to make major contributions to neuroscience. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a level commensurate with a PD/PI's recent NINDS support (Part 2, Section II) This greater funding stability will provide eligible investigators at nearly all career stages increased freedom and flexibility, allowing them to be more adventurous in their research, take greater risks, embark upon research that breaks new ground, undertake research projects that require a longer timeframe, and/or extend previous discoveries in new directions. Research supported through the RPA must be within the scope of the NINDS mission (http://www.ninds.nih.gov/about_ninds/mission.htm). Research activities outside of the NINDS mission, or traditionally supported by another NIH Institute or Center will not be considered through this program. Other anticipated benefits of the RPA include: A more stable funding environment, facilitating the pursuit of longer-term research goals; Flexible funding, enabling investigators to pursue research opportunities as they arise, not tied to specific aims; Reduced time spent writing grant applications and managing multiple grant awards, thereby allowing investigators to spend more time conducting and overseeing research; and More time for PDs/PIsto mentor junior scientists. Eligibility to apply through this FOA is limited to investigators who currently have at least one active NINDS R01 or R01 equivalent grant (defined here as R00, R01, R37, R56, DP1 or DP2 awards), and who have had an active R01 equivalent grant from NINDS in each of the past 5 years, with no more than one of those years in a no cost extension.

Notice NOT-AG-20-032 from the NIH Guide for Grants and Contracts